2005
DOI: 10.1080/00365520510024232
|View full text |Cite
|
Sign up to set email alerts
|

Elevated serum CA 19-9 in hepatic actinomycosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 5 publications
0
6
0
Order By: Relevance
“…With these types of benign conditions the elevation of CA19-9 is often lower than malignant conditions. At a level of 1000 U/ml the marker's positive predictive value approaches 100% [8]. In our patient the CA19-9 level was 49.6 U/ml, which may have been an indication that her presenting symptoms were not secondary to a malignant process.…”
Section: Discussionmentioning
confidence: 63%
See 1 more Smart Citation
“…With these types of benign conditions the elevation of CA19-9 is often lower than malignant conditions. At a level of 1000 U/ml the marker's positive predictive value approaches 100% [8]. In our patient the CA19-9 level was 49.6 U/ml, which may have been an indication that her presenting symptoms were not secondary to a malignant process.…”
Section: Discussionmentioning
confidence: 63%
“…CA19-9 is a carbohydrate epitope that is sialylated on the surface of certain tumors. It is not organ specific and is clinically used as a marker of pancreatic, hepatobiliary and gastric malignancies [8]. This marker is often elevated in benign disease states of the hepatobiliary system, renal failure, pleural effusion, intestinal pneumonia and systemic lupus erythematosus.…”
Section: Discussionmentioning
confidence: 99%
“…Anemia, leukocytosis, ESR and CRP elevations, and prolongation of PT and activated partial thromboplastin time may be present in actinomycosis. Additionally, it may elevate serum levels of CA 19-9 [3] .…”
Section: Resultsmentioning
confidence: 99%
“…A yellowish vaginal discharge with foul odor was present on speculum examination. Laboratory data were notable for a white blood cell count of 12,610 cells/mm 3 (4,000-10,000 cells/mm 3 ), hemoglobin of 9.3 g/dl (12.0-16.0 g/dl), erythrocyte sedimentation rate (ESR) 101 mm/h (0-20 mm/h), C-reactive protein (CRP) 8.34 mg/dl (0-1.0 mg/dl), and prothrombin time (PT), r -glutamyl transpeptidase ( r -GTP), alkaline phosphatase (ALP) values of 1.26 INR (0.8-1.2 INR), 76 IU/l (8-35 IU/l), and 136 IU/l (30-115 IU/l), respectively. Relevant tumor markers did not exceed accepted normal ranges, i.e., alpha fetoprotein ( ␣ FP) 5 ng/ml, carcinoembryonic antigen (CEA) 1.1 ng/ml, carbohydrate antigen 19-9 (CA 19-9) 5 U/ml, cancer antigen 125 (CA 125) 16 U/ml, beta human chorionic gonadotropin ( ␤ -hCG) 4 mIU/ml.…”
Section: Introductionmentioning
confidence: 99%
“…The CA19-9 level is often elevated in benign diseases of the hepatobiliary system, renal failure, pleural effusion, intestinal pneumonia, and systemic lupus erythematosus. However, the level of elevation in these benign conditions is often lower than that in malignant conditions [9,10]. Despite these benefits, CA19-9 has inadequate sensitivity and specificity to be used as a marker for differentiating hepatic actinomycosis from liver tumors [11,12].…”
Section: Discussionmentioning
confidence: 99%